Evidence map›Paper›PMID 39412213›Full record

ArticleClinical and translational medicine2024

BIN2 inhibition suppress ovarian cancer progression meanwhile protect ovarian function through downregulating HDAC1 and RPS6 phosphorylation respectively.

Cong-Rong Li, Shi-Ya Xie, Shu-Ping Zhang, Yan-Jie Yang, Li-Li Yang, Ying Cao, Li-Li Wang, Feng-Yu Zhu, Ruo-Lei Wang, Zhi-Xia Yang and 12 more

Abstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Clinical and translational medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors.

Cong-Rong LiDepartment of Gynaecology and Obstetrics, the First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China.
Shi-Ya XieDepartment of Gynaecology and Obstetrics, the First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China.
Shu-Ping ZhangDepartment of Gynaecology and Obstetrics, the First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China.
Yan-Jie YangDepartment of Gynaecology and Obstetrics, the First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China.
Li-Li YangDepartment of Gynaecology and Obstetrics, the Second Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China.
Ying CaoDepartment of Gynaecology and Obstetrics, the Second Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China.
Li-Li WangState Key Lab of Reproductive Medicine and Offspring Health, Nanjing Medical University, Nanjing, Jiangsu, China.
Feng-Yu ZhuState Key Lab of Reproductive Medicine and Offspring Health, Nanjing Medical University, Nanjing, Jiangsu, China.
Ruo-Lei WangState Key Lab of Reproductive Medicine and Offspring Health, Nanjing Medical University, Nanjing, Jiangsu, China.
Zhi-Xia YangDepartment of Gynaecology and Obstetrics, the First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China.
Chen-Chen CuiReproductive Medical Center, Henan Provincial People's Hospital & People's Hospital of Zhengzhou University, Zhengzhou, Henan, China.
Yan-Ru LiReproductive Medical Center, Henan Provincial People's Hospital & People's Hospital of Zhengzhou University, Zhengzhou, Henan, China.
Jia-Ning XuReproductive Medical Center, Henan Provincial People's Hospital & People's Hospital of Zhengzhou University, Zhengzhou, Henan, China.
Feng YueReproductive Medical Center, Henan Provincial People's Hospital & People's Hospital of Zhengzhou University, Zhengzhou, Henan, China.
Pei-Zhe TianReproductive Medical Center, Henan Provincial People's Hospital & People's Hospital of Zhengzhou University, Zhengzhou, Henan, China.
Qian WangReproductive Medical Center, Henan Provincial People's Hospital & People's Hospital of Zhengzhou University, Zhengzhou, Henan, China.
Hong-Jie YaoGuangzhou National Laboratory, University of Chinese Academy of Sciences, Guangzhou, Guangdong, China.
Yi-Chun GuanCenter for Reproductive Medicine, the Third Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.
Shao-Di ZhangReproductive Medical Center, Henan Provincial People's Hospital & People's Hospital of Zhengzhou University, Zhengzhou, Henan, China.
Xiao-Yan YingDepartment of Gynaecology and Obstetrics, the Second Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China.
Dong ZhangDepartment of Gynaecology and Obstetrics, the First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China.ORCID 0000-0002-0257-4441
Cui-Lian ZhangReproductive Medical Center, Henan Provincial People's Hospital & People's Hospital of Zhengzhou University, Zhengzhou, Henan, China.

Funding

Jiangsu Provincial Key Department of Maternal and Child Health Fund FXK201712Major Projects in Provincial and National Union Construction of Henan Medical Science Research Plan SBGJ202001002National Key R&D Program of China 2021YFA1100300National Key Research & Development Project 2021YFC2700602National Natural Science Foundation of China 32070840
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Histone Deacetylase 1Ovarian NeoplasmsAdaptor Proteins, Signal TransducingAnimalsDisease ProgressionDown-RegulationFemaleHumansMiceOvaryPhosphorylationRibosomal ProteinsTumor Suppressor ProteinsAdaptor Proteins, Signal TransducingHDAC1 protein, humanHistone Deacetylase 1Ribosomal ProteinsTumor Suppressor Proteins

Identifiers

PMID39412213
PMCPMC11480968

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.